(NASDAQ: KOD) Kodiak Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 82.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.98%.
Kodiak Sciences's revenue in 2025 is $0.On average, 3 Wall Street analysts forecast KOD's revenue for 2027 to be $2,862,935,544, with the lowest KOD revenue forecast at $1,846,118,031, and the highest KOD revenue forecast at $4,365,712,596. On average, 1 Wall Street analysts forecast KOD's revenue for 2028 to be $5,837,853,068, with the lowest KOD revenue forecast at $5,837,853,068, and the highest KOD revenue forecast at $5,837,853,068.
In 2029, KOD is forecast to generate $11,643,484,906 in revenue, with the lowest revenue forecast at $11,643,484,906 and the highest revenue forecast at $11,643,484,906.